Literature DB >> 30705045

Association of human antigen class I genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population.

Ikhyun Jun1,2, John Hoon Rim2,3, Mee Kum Kim4, Kyung-Chul Yoon5, Choun-Ki Joo6, Shigeru Kinoshita7, Kyoung Yul Seo8, Mayumi Ueta9.   

Abstract

BACKGROUND/AIMS: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are a spectrum of diseases that cause an acute vesiculobullous reaction in the skin and mucous membranes. The occurrence of these diseases is associated with various drugs, a large proportion of which is comprised cold medicines (CM). We try to investigate the association between human leucocyte antigen (HLA) class I genes and CM-related SJS/TEN (CM-SJS/TEN) with severe ocular complications (SOC) in the Korean population.
METHODS: This multicentre case-control study enrolled 40 Korean patients with CM-SJS/TEN with SOC and 120 age-matched and sex-matched Korean healthy volunteers between January 2012 and May 2014. HLA genotyping was performed using PCR followed by hybridisation with sequence-specific oligonucleotide probes. RESULTS : The carrier frequency and gene frequency of HLA-A*02:06 were 37.5 % and 20.0 %, respectively, in patients, and 16.7 % and 9.6 %, respectively, in controls (p=0.018). The carrier frequency of HLA-C*03:04 was 30 % in patients and 10.8 % in controls, and gene frequency of HLA-C*03:04 was 15 % in patients and 5.4 % in controls (p=0.003). The carrier frequency and gene frequency of HLA-C*03:03 were 2.5 % and 1.3 %, respectively, in patients, and 20 % and 10.4 %, respectively, in controls (p=0.006). CONCLUSIONS : As per our results, we suggest that HLA-A*02:06 and HLA-C*03:04 might be positive markers for CM-SJS/TEN with SOC, and HLA-C*03:03 might be an indicator of protection against CM-SJS/TEN with SOC in the Korean population. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  experimental &#8211 laboratory; genetics; ocular surface

Mesh:

Year:  2019        PMID: 30705045     DOI: 10.1136/bjophthalmol-2018-313263

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  HLA genotypes and cold medicine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis.

Authors:  Wimonchat Tangamornsuksan; Sirikan Chanprasert; Phenphechaya Nadee; Saowalak Rungruang; Natnaree Meesilsat; Mayumi Ueta; Manupat Lohitnavy
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

Review 2.  Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications.

Authors:  Mayumi Ueta
Journal:  Front Med (Lausanne)       Date:  2021-12-01

Review 3.  Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC.

Authors:  Mayumi Ueta
Journal:  Front Genet       Date:  2022-07-11       Impact factor: 4.772

Review 4.  Genetics of Severe Cutaneous Adverse Reactions.

Authors:  Shang-Chen Yang; Chun-Bing Chen; Mao-Ying Lin; Zhi-Yang Zhang; Xiao-Yan Jia; Ming Huang; Ya-Fen Zou; Wen-Hung Chung
Journal:  Front Med (Lausanne)       Date:  2021-07-15

5.  Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens-Johnson syndrome with severe ocular complications in Japanese individuals.

Authors:  Mayumi Ueta; Ryosuke Nakamura; Yoshiro Saito; Katsushi Tokunaga; Chie Sotozono; Toshio Yabe; Michiko Aihara; Kayoko Matsunaga; Shigeru Kinoshita
Journal:  Hum Genome Var       Date:  2019-10-28

Review 6.  HLA-associated adverse drug reactions - scoping review.

Authors:  Chiara Jeiziner; Ursina Wernli; Katja Suter; Kurt E Hersberger; Henriette E Meyer Zu Schwabedissen
Journal:  Clin Transl Sci       Date:  2021-06-09       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.